Global biotech company BeiGene Ltd has reportedly opened a regional office in Basel, Switzerland to serve as a European operational hub for the company.

John V. Oyler, Chairman, Co-Founder, and CEO at BeiGene stated that the new office in Basel builds the remarkable growth of the company in Europe and it will offer a new operational center in the region.

Founded in 2010, BeiGene currently has a global team of more than 8,000 colleagues across five continents. The company’s European organization comprises over 270 colleagues and the Basel office will initially include 150 colleagues.

BeiGene performs clinical trials across the world and has admitted patients from 45 countries, including 25 European nations.

Zanubrutinib, the company’s BTK inhibitor, received approval from the European Medicines Agency in November last year for treating adults with macroglobulinemia of Waldenström and received approvals in Switzerland and Great Britain.

For the opening ceremony, BeiGene hosted many regional business leaders and government representatives to discuss the importance of biotech leaders like BeiGene to the Basel region.

According to Deborah Strub, Head of the Cluster & Initiatives Department at the Basel Chamber of Commerce, BeiGene's presence represents a greater avenue for the Swiss as well as the Basel economy to thrive and collaborate.

Strub added that the life sciences vertical is the region’s economic engine and with BeiGene, the organization seeks avenues for interesting exchanges and synergies.

Apart from the new Basel office, BeiGene has regional offices in Beijing, China, and Cambridge, Massachusetts with more than 30 office locations worldwide.

For the record, BeiGene has a thriving team of medical affairs and R&D of 2,900 colleagues committed to upgrading over 100 clinical trials that involved over 16,000 subjects.

The company’s extensive portfolio is directed by its internal colleagues backing clinical trials in over 45 countries and regions.

Source credit:

https://ir.beigene.com/news/beigene-strengthens-european-presence-with-the-opening-of-regional-office-in-basel-switzerland/55c4b837-b084-4b20-91ac-b55b698e7fbc/